Followers | 44 |
Posts | 11566 |
Boards Moderated | 0 |
Alias Born | 09/24/2011 |
Thursday, November 23, 2017 1:32:21 PM
Technology, Inc. (“MIT”) (OTC PINK:MMTC) -- MIT and their collaborators in the
lab of Dr. Josh Sharp of Northern Michigan University have jointly published a
paper in the peer reviewed Journal of AOAC International. The paper describes
the technology behind the MIT 1000 and identification testing relating to the
bacterial genus, Staphylococcus.
The paper is available, pre-publication, through the Journal's fast track web
page. The article may be viewed at this
address: http://aoac.publisher.ingentaconnect.com/content/aoac/jaoac/pre-prints/content-jaoac_170097.
The paper will be published in volume 100 issue number 6 of the Journal of
AOAC International. After it is published it will then be available as an open
access article via the Journal's content web
page: http://aoac.publisher.ingentaconnect.com/content/aoac/jaoac.
The MIT 1000 is a rapid, bacterial cell-based detection and identification
system that can identify pathogenic bacteria, now including S. aureus.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM